Cartesian Therapeutics, Inc. (RNAC) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.02 | -11.8% |
| 2024 | $-4.49 | +91.0% |
| 2023 | $-49.76 | -49860.0% |
| 2022 | $0.10 | +145.5% |
| 2021 | $-0.22 | +67.6% |
| 2020 | $-0.68 | +44.3% |
| 2019 | $-1.22 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.02 | -11.8% |
| 2024 | $-4.49 | +91.0% |
| 2023 | $-49.76 | -49860.0% |
| 2022 | $0.10 | +145.5% |
| 2021 | $-0.22 | +67.6% |
| 2020 | $-0.68 | +44.3% |
| 2019 | $-1.22 | — |